Optimising therapeutic strategies to address complex clinical
Clinical Professor, Haematology
The University of Dublin
The full programme is HERE
Who should attend?
This meeting is ideal for:
- Researchers and
and any healthcare professionals who have an interest in the future shape and direction of FL & CLL research and treatment.
When & Where
Thursday 11th October 2018, 18:00 – 19:30
The Radisson Blu Hotel
Ditchley House – Little Island,
Little Island Business Park,
The meeting costs are underwritten by Gilead Sciences Ltd. and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity.
Date of preparation: June 2019
This activity is intended for medical Haematology/Oncology healthcare professionals, scientists and academics involved in the management of, and research into CAR T-cell therapy in patients with high-grade lymphoid malignancies, specifically relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma (PMBCL), as well as those with interest in the wider treatment landscape of haematological malignancies. Data on licensed CAR-T products will be presented.